A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

Recruiting

I'm Interested

Trial ID: NCT04260256

Age - 18 Years-N/A Condition - Any Cancer Condition or Solid Tumor Gender - ALL Accepting Healthy Volunteers - No

Purpose

In this study, patients with advanced solid tumors will undergo \[18F\]F AraG PET/CT imaging to assess for changes in tracer uptake following treatment with CkIT.

Official Title

A Pilot Study of Using [18F]F AraG PET Imaging to Evaluate the Immunological Response to Checkpoint Inhibitor Therapy (CkIT) in Patients With Advanced Solid Tumors

Stanford Investigator(s)

Carina Mari Aparici
Carina Mari Aparici

Clinical Professor, Radiology - Rad/Nuclear Medicine

Eligibility

Inclusion Criteria:

* Solid tumor with planned CkIT
* Must be \>18 years old
* Signed Informed Consent Form
* Patient must have two qualifying lesions

Exclusion Criteria:

* Patient is pregnant or breast feeding

View More
View Less

Intervention(s):

drug: [18F]F-AraG

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Kavin Tamizhmani
(650)-497-6046

New Trial Alerts

©2025 Stanford Medicine